Death Letter
The researchers were interested in whether receipt of such a letter would cause the physician to be more cautious in prescribing in future. The answer: It did.
Select Page
by C. Scott McMillin | Feb 27, 2023 | Addictive Substances | 0 |
The researchers were interested in whether receipt of such a letter would cause the physician to be more cautious in prescribing in future. The answer: It did.
by C. Scott McMillin | Feb 23, 2023 | Addictive Substances | 0 |
by C. Scott McMillin | Feb 20, 2023 | In the News | 0 |
by C. Scott McMillin | Feb 16, 2023 | Addictive Substances | 0 |
by C. Scott McMillin | Feb 13, 2023 | Addictive Substances | 0 |
by C. Scott McMillin | Jan 16, 2023 | Addictive Substances | 0 |
by C. Scott McMillin | Jan 9, 2023 | Addictive Substances | 0 |
…how cannabis is covered in the media reinforces and can strengthen the user’s faith in the value of cannabis – well beyond the science, as the saying goes.
Read Moreby C. Scott McMillin | Dec 15, 2022 | Resources | 1 |
Where fentanyl is present, single doses of naloxone often prove inadequate.
Read Moreby C. Scott McMillin | Dec 12, 2022 | Resources | 0 |
If someone was sick enough at some point to have been hospitalized for treatment of an SUD, they’re statistically more likely to suffer from other diseases later in life.
Read Moreby C. Scott McMillin | Nov 14, 2022 | Addictive Substances | 0 |
Use of higher potency cannabis products does appear to raise the user’s risk of both Cannabis Use Disorders (CUD) and psychosis. The association was less clear for depression and anxiety.
Read Moreby C. Scott McMillin | Oct 20, 2022 | Addictive Substances, In the News | 0 |
I’m sure this is helpful information but I’d be more interested in something new on CUD patients with more severe DSM5 profiles.
Read Moreby C. Scott McMillin | Oct 10, 2022 | Addictive Substances | 0 |
I was surprised to learn that the antidepressant effects of ketamine were completely blocked by naltrexone, an opioid antagonist. That certainly suggests ketamine is making use of the brain’s opioid systems…
Read Moreby C. Scott McMillin | Aug 18, 2022 | Recovery | 0 |
That reminded me of the advice given to newcomers who thought they didn’t need treatment, to “give it your best shot, and if things don’t work out, come back and see us.”
Read Moreby C. Scott McMillin | Jul 28, 2022 | Thinking About Addiction | 0 |
…no more than 7.4% of overdose patients had received a prescription for naloxone following an overdose. That covers both the initial visit and any follow-up contacts the hospital required.
Read Moreby C. Scott McMillin | Jul 7, 2022 | Treatment | 0 |
It may be that psychotherapy itself needs greater definition. The National Institutes for Mental Health define it online as “a term for a variety of treatment techniques that aim to help a person identify and change troubling emotions, thoughts, and behavior.”
Read Moreby C. Scott McMillin | Jun 27, 2022 | Thinking About Addiction | 0 |
We recognize the important role that depression and anxiety play in determining the patient’s experience of pain.
Read Moreby C. Scott McMillin | Jun 16, 2022 | Addictive Substances | 0 |
I wish cannabis was effective for the treatment of opioid disorders. I mean, we could use the help. But so far, it doesn’t appear to qualify.
Read Moreby C. Scott McMillin | Jun 13, 2022 | Addiction Clinicians | 0 |
I noticed early on that some clinicians appeared to acclimate to the telehealth model far more easily than other did.
Read More